International Journal of Infection

Published by: Kowsar

Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever

Seyed Mohammad Hashemi-Shahri 1 , Batool Sharifi-Mood 1 , * and Maliheh Metanat 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: September 20, 2014, 1 (3); e21519
  • Published Online: September 10, 2014
  • Article Type: Research Article
  • Received: April 10, 2014
  • Revised: June 29, 2014
  • Accepted: July 20, 2014
  • DOI: 10.17795/iji-21519

To Cite: Hashemi-Shahri S M, Sharifi-Mood B, Metanat M. Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever, Int J Infect. 2014 ; 1(3):e21519. doi: 10.17795/iji-21519.

Abstract
Copyright © 2014, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. W.H.O. . Crimean-Congo haemorrhagic fever (CCHF). World Health Organization 2014;
  • 2. Chinikar S, Ghiasi SM, Moradi M, Goya MM, Shirzadi MR, Zeinali M, et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis. 2010; 10(7): 705-8[DOI][PubMed]
  • 3. Metanat M, Sharifi-Mood B, Tabatabaei M, Shirazi MS. Can Serum Ferritin Level Predict Disease Severity in Patients with Crimean-Congo Hemorrhagic Fever? Eurasian J Med. 2013; 48: 108-14
  • 4. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med. 2007; 10(2): 204-14[PubMed]
  • 5. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect. 2006; 52(5): 378-82[DOI][PubMed]
  • 6. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
  • 7. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med. 2009; 12(2): 151-3[PubMed]
  • 8. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8[DOI][PubMed]
  • 9. Mardani M, Poorkaveh B. Crimean-Congo Hemorrhagic Fever. Iran J Clin Infect Dis. 2012; 7(1): 36-9
  • 10. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006; 12(6): 551-4[DOI][PubMed]
  • 11. Brug J, Aro AR, Oenema A, de Zwart O, Richardus JH, Bishop GD. SARS risk perception, knowledge, precautions, and information sources, the Netherlands. Emerg Infect Dis. 2004; 10(8): 1486-9[DOI][PubMed]
  • 12. Oflaz MB, Bolat F, Kaya A, Guven AS, Kucukdurmaz Z, Karapinar H, et al. Resting heart rate in children with Crimean-Congo hemorrhagic fever: a tool to identify patients at risk? Vector Borne Zoonotic Dis. 2014; 14(1): 59-65[DOI][PubMed]
  • 13. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct. 2009; 39(3): 158-60[DOI][PubMed]
  • 14. Tabatabaei SM, Hassanzehi A, Pakzad A, Mohammadi M, Madani M. Factors Influencing Crimean-Congo Hemorrhagic Fever Risk Perceptions in the General Population, Southeast Iran. Int J Infection. 2014; 1(1)
  • 15. Chinikar S, Mazaheri V, Mirahmadi R, Nabeth P, Francoise-Saron M, Salehi P. Serological survey in suspected human patients of CCHF in Iran by determination of IgM-ELISA method during 2000–2004. Arch Iran Med. 2006; 8: 52-5
  • 16. Mardani M, Keshtkar JM, Holakoi N, Zinali M. The efficacy of oral ribavirin in the treatment of 81 proved cases of Crimean-Congo hemorrhagic fever in Iran (1991–2001). Med J I R Iran. 2003; 3: 193-5
  • 17. Metanat M, Sharifi-Mood B, Salehi M, Alavi-Naini R. Clinical outcomes in Crimean-Congo hemorrhagic fever: A five-years experience in the treatment of patients in oral Ribavirin. Int J Virol. 2006; 2: 21-4
  • 18. Sharifi Mood B, Alavi-Naini R, Metanat M, Rakhshani F. Ribavirin: an effective drug for treatment of children with Crimean Congo hemorrhagic fever: a seven years experience. Pak J Biolo Sci. 2006; 9: 1598-600
  • 19. Rakhshani M, Abedi-poou F, Noori-Jangi M, Khorgami P, Hajalizadeh A. A five-member family with Crimean-Congohemorrhagic fever;A case series study. Int J infection. 2014; 1(1)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments